Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Elke Raes is active.

Publication


Featured researches published by Elke Raes.


Therapeutic Drug Monitoring | 2009

Relationship Between Oral Fluid and Blood Concentrations of Drugs of Abuse in Drivers Suspected of Driving Under the Influence of Drugs

Sarah M.R. Wille; Elke Raes; Pirjo M. Lillsunde; Teemu Gunnar; Marleen Laloup; Nele Samyn; Asbjørg S. Christophersen; Manfred R. Moeller; Karin Hammer; Alain Verstraete

In recent years, the interest in the use of oral fluid as a biological matrix has increased significantly, particularly for detecting driving under the influence of drugs (DUID). In this study, the relationship between the oral fluid and the blood concentrations of drugs of abuse in drivers suspected of DUID is discussed. Blood and oral fluid samples were collected from drivers suspected of DUID or stopped during random controls by the police in Belgium, Germany, Finland, and Norway for the ROSITA-2 project. The blood samples were analyzed by gas chromatography-mass spectrometry (GC-MS) or liquid chromatography-mass spectrometry (LC-MS), sometimes preceded by immunoassay screening of blood or urine samples. The oral fluid samples were analyzed by GC-MS or LC-MS(/MS). Scatter plots and trend lines of the blood and oral fluid concentrations and the median, mean, range, and SD of the oral fluid to blood (OF:B) ratios were calculated for amphetamines, benzodiazepines, cocaine, opiates, and ▵9-2 tetrahydrocannabinol. The ratios found in this study were comparable with those that were published previously, but the range was wider. The OF:B ratios of basic drugs such as amphetamines, cocaine, and opiates were >1 [amphetamine: median (range) 13 (0.5-182), methylenedioxyamphetamine: 4 (1-15), methylenedioxymethamphetamine: 6 (0.9-88), methamphetamine: 5 (2-23), cocaine: 22 (4-119), benzoylecgonine: 1 (0.2-11), morphine: 2 (0.8-6), and codeine: 10 (0.8-39)]. The ratios for benzodiazepines were very low, as could be expected as they are highly protein bound and weakly acidic, leading to low oral fluid concentrations [diazepam: 0.02 (0.01-0.15), nordiazepam: 0.04 (0.01-0.23), oxazepam: 0.05 (0.03-0.14), and temazepam: 0.1 (0.06-0.54)]. For tetrahydrocannabinol, an OF:B ratio of 15 was found (range 0.01-569). In this study, the time of last administration, the dose, and the route of administration were unknown. Nevertheless, the data reflect the variability of the OF:B ratios in drivers thought to be under the influence of drugs. The wide range of the ratios, however, does not allow reliable calculation of the blood concentrations from oral fluid concentrations.


Annales pharmaceutiques françaises | 2006

Cannabis et conduite automobile: la situation en Europe

Elke Raes; Alain Verstraete

Resume En Europe, trois millions de personnes consomment quotidiennement du cannabis. Des enquetes ont demontre que plus des deux tiers des consommateurs de drogue conduisent apres avoir fume du cannabis. Les etudes epidemiologiques demontrent que le pourcentage de la population generale des conducteurs positifs au cannabis varie entre 0,5 % et 8,2 %. Chez les conducteurs blesses ou decedes suite a un accident, le pourcentage varie respectivement de 3,3 % a 10 % et de 2,2 % a 8,4 %. Enfin, des pourcentages tres eleves sont trouves dans les etudes qui ont recherche les drogues chez les conducteurs suspectes de conduite sous l′influence des drogues : plus de 50 % en Allemagne, en Autriche, en Belgique, au Royaume-Uni et en Suisse. Six pays europeens ont adopte une legislation analytique ou « per se » et les seuils de positivite varient entre 0,3 et 2 ng/mL de THC. Aux Pays-Bas, des etudes experimentales effectuees apres administration de cannabis ont clairement demontre les effets deleteres, en particulier en cas de consommation simultanee de cannabis et d′alcool. Differents projets de recherche finances par l′Union europeenne ont etudie les aspects epidemiologiques (IMMORTAL), la detection par tests psychotechniques (CERTIFIED) et la detection de drogues au bord de la route (ROSITA et ROSITA-2).


Handbook of Analytical Separations | 2008

Chapter 19 Drugs and driving

Elke Raes; Alain Verstraete; R. Wennig

Publisher Summary This chapter discusses drugs and driving. Every year, more than a million people are killed and many millions more are injured in traffic crashes. Traffic crashes are the consequence of many factors, which can be classified into three categories: the road, the vehicle, and the driver. A crash is rarely attributable to only one factor; therefore, it is very difficult to determine in what percentage of crashes alcohol or drugs have contributed. Toxicological analysis can be performed on samples of drivers suspected of “driving under the influence of drugs” (DUID) and drivers injured or killed as a consequence of a traffic accident, and on samples of drivers that were collected during roadside surveys. A typical procedure of toxicological analysis involves two steps: screening and confirmation. Usually an immunoassay followed by a chromatographic method is performed: the first allows for a preliminary monitoring of a large number of samples in a reduced period of time; while the second step provides the required specificity. There has recently been an increase in the repertoire of immunoassays now available with the techniques becoming increasingly more specific for the drugs and/or metabolites being monitored.


EMCDDA Insights | 2008

Drug use, impaired driving and traffic accidents

Elke Raes; Thomas Van den Neste; Alain Verstraete; Dominique Lopez; Brendan Hughes; Paul D. Griffiths


Archive | 2006

Rosita-2 project: final report

Alain Verstraete; Elke Raes


Journal of Analytical Toxicology | 2005

Usefulness of Roadside Urine Drug Screening in Drivers Suspected of Driving Under the Influence of Drugs (DUID)

Elke Raes; Alain Verstraete


Forensic Science International Supplement Series | 2009

The toxicological challenges in the European research project DRUID

Kristof Pil; Elke Raes; Alain Verstraete


Annales pharmaceutiques françaises | 2008

[Illicit drugs, medications and traffic accidents].

Jean-Pierre Goullé; Alain Verstraete; R. Boulu; J. Costentin; J-P Foucher; Elke Raes; J-P Tillement


DRUID, Driving under the Influence of Drugs, Alcohol and Medicines, EU 6th Framework Programme | 2007

Uniform design and protocols for carrying out case-control studies

Inger Marie Bernhoft; Tove Hels; Allan Steen Hansen; Terje Assum; G. Frison; Sjoerd Houwing; Rene Mathijssen; J. Commandeur; Kristof Pil; Elke Raes; T. Van den Neste; Alain Verstraete; C. Engblom; A. Rantanen; J. Haukka


Forensic Science International Supplement Series | 2009

The modern trends in alcohol, drugs and driving research

Elke Raes; Kristof Pil; Alain Verstraete

Collaboration


Dive into the Elke Raes's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Robert Wennig

University of Luxembourg

View shared research outputs
Top Co-Authors

Avatar

Brendan Hughes

European Monitoring Centre for Drugs and Drug Addiction

View shared research outputs
Top Co-Authors

Avatar

Dominique Lopez

European Monitoring Centre for Drugs and Drug Addiction

View shared research outputs
Top Co-Authors

Avatar

Nele Samyn

Aristotle University of Thessaloniki

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Allan Steen Hansen

Technical University of Denmark

View shared research outputs
Top Co-Authors

Avatar

Inger Marie Bernhoft

Technical University of Denmark

View shared research outputs
Researchain Logo
Decentralizing Knowledge